828 related articles for article (PubMed ID: 21198520)
1. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
Rademaker M
Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
[TBL] [Abstract][Full Text] [Related]
2. Low-dose schema of isotretinoin in acne vulgaris.
Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
[TBL] [Abstract][Full Text] [Related]
3. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
4. On isotretinoin dosing, adverse effects, and efficacy.
Berk DR
Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
[No Abstract] [Full Text] [Related]
5. Isotretinoin updates.
On SC; Zeichner J
Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric reactions to isotretinoin in patients with bipolar disorder.
Schaffer LC; Schaffer CB; Hunter S; Miller A
J Affect Disord; 2010 May; 122(3):306-8. PubMed ID: 19783054
[TBL] [Abstract][Full Text] [Related]
7. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
[No Abstract] [Full Text] [Related]
8. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
9. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
[TBL] [Abstract][Full Text] [Related]
10. Acute myopathy and acne fulminans triggered by isotretinoin therapy.
Sarifakioglu E; Onur O; Kart H; Yilmaz AE
Eur J Dermatol; 2011; 21(5):794-5. PubMed ID: 21727056
[No Abstract] [Full Text] [Related]
11. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
12. Safety issues in isotretinoin therapy.
Hanson N; Leachman S
Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
[TBL] [Abstract][Full Text] [Related]
14. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
Layton AM; Dréno B; Gollnick H; Mobaken H; Shear N
Br J Dermatol; 2009 Jan; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
[No Abstract] [Full Text] [Related]
15. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
DiGiovanna JJ; Langman CB; Tschen EH; Jones T; Menter A; Lowe NJ; Eichenfield L; Hebert AA; Pariser D; Savin RP; Smith SR; Jarratt M; Rodriguez D; Chalker DK; Kempers S; Ling M; Rafal ES; Sullivan S; Kang S; Shah LP; Wu E; Newhouse J; Pak J; Eberhardt DR; Bryce GF; McLane JA; Ondovik M; Chin C; Khoo KC; Rich P
J Am Acad Dermatol; 2004 Nov; 51(5):709-17. PubMed ID: 15523348
[TBL] [Abstract][Full Text] [Related]
16. Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study.
Nevoralová Z; Dvořáková D
Int J Dermatol; 2013 Feb; 52(2):163-8. PubMed ID: 23347302
[TBL] [Abstract][Full Text] [Related]
17. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T
Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
[TBL] [Abstract][Full Text] [Related]
18. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
Kaymak Y; Ilter N
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
